Hosted by Raybow Pharmaceutical, Dr. Andreas Flueckiger presented with Dr. Dirk Hütten moderating. Webinar includes a Q&A.
The safe handling of hazardous substances depends on the correct determination of their toxicity. This webinar describes this process. Its result is a health-based exposure limit for each compound. The corresponding guidelines, case studies and the benefits to emerging and established pharma are presented.
PresentersDr. Andreas Flueckiger will present with Dr. Dirk Hütten moderating.
Andreas Flueckiger is a specialist in internal and in occupational medicine. He was the Global Head of Occupational Health and Occupational Toxicology of one of the world’s top three pharmaceutical companies for >30 years. During this time, he and his department set over 2000 limits values for APIs, synthesis intermediates and other chemicals. As these limits are a determinant for the engineering controls necessary to safely handle these molecules, he has gained ample expertise in containment solutions and industrial hygiene assessments at the workplaces and related GMP matters.
Dirk HüttenSenior Director Business DevelopmentRaybow Pharmaceutical
Dr. Dirk Hütten holds a PhD in Chemistry from the University of Cologne, Germany. He has more than 20 years of experience in global sales and marketing alongside the supply chain of pharmaceuticals and APIs including positions at GSK, Altana and PharmaZell. In 2019, he joined Raybow Pharmaceutical as Senior Director Business Development. In addition, Dirk is passionate about high performance sailing.